ROLE OF NEUROMODULATION IN MIGRAINE
The RELIEV-CM2 clinical study will investigate the first-ever, head located implantable neuromodulation devicedesigned to treat Chronic Migraine.
The RELIEV-CM2 clinical study will investigate the first-ever, head located implantable neuromodulation devicedesigned to treat Chronic Migraine.
We welcome Penney Cowan to the podium for the 8th lecture honoring the foundational contributions of leaders in pain medicine.
#10 in the NIH Pain Consortium Grant-Mechanism Webinar Series The goal of this webinar series is to inform the pain research community of funding opportunities and other resources provided by the NIH. There is no cost for these webinars, but attendees must register in advance.
